|
gptkbp:instanceOf
|
gptkb:company
|
|
gptkbp:acquiredBy
|
gptkb:Absorption_Systems_(2020)
gptkb:Covance_China_(2018)
Aesica Pharmaceuticals (2021)
|
|
gptkbp:country
|
gptkb:China
|
|
gptkbp:founded
|
2004
|
|
gptkbp:founder
|
gptkb:Boliang_Lou
|
|
gptkbp:headquarters_location
|
gptkb:Beijing
|
|
gptkbp:industry
|
gptkb:contract_research_organization
pharmaceuticals
|
|
gptkbp:keyPerson
|
gptkb:Boliang_Lou
gptkb:Yonghua_Wang
Yong Zhi
|
|
gptkbp:location
|
gptkb:China
gptkb:Europe
gptkb:United_Kingdom
gptkb:United_States
|
|
gptkbp:numberOfEmployees
|
over 14,000
|
|
gptkbp:revenue
|
over 10 billion RMB (2022)
|
|
gptkbp:servesArea
|
global
|
|
gptkbp:service
|
manufacturing
drug discovery
clinical development
preclinical development
|
|
gptkbp:stockExchange
|
gptkb:Hong_Kong_Stock_Exchange
gptkb:Shenzhen_Stock_Exchange
|
|
gptkbp:stockSymbol
|
gptkb:300759.SZ
gptkb:3759.HK
|
|
gptkbp:subsidiary
|
gptkb:Absorption_Systems
gptkb:Covance_(China_operations_acquired)
|
|
gptkbp:website
|
https://www.pharmaron.com/
|
|
gptkbp:bfsParent
|
gptkb:Zhangjiang
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Pharmaron
|